MYND Life Sciences Announces Strategic Debt Reduction and New Board Member Appointment @IncMynd #Chemicals #Biotechnology #Appointment #CSEStocks #OTC #OTCMarkets #OTCStocks #SmallCaps #Investing
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a leader in mental health diagnostics and treatments, today announced two significant strategic decisions aimed at strengthening the company's financial position and governance. These moves demonstrate a strong commitment to the company's vision and strategic plan to commercialize a diagnostic biomarker test for depression which is being initially...
http://dlvr.it/TGLRw2
http://dlvr.it/TGLRw2
Comments
Post a Comment